Intuitive Surgical Stock: Bear vs. Bull
If you've ever had minimally invasive surgery, you may have come into contact with Intuitive Surgical's (NASDAQ: ISRG) flagship product: the Da Vinci robot. Surgeons worldwide use the Da Vinci for various procedures, from hernia repair to prostate surgery. In fact, Intuitive is the global robotic surgery leader, with a market share of nearly 80%.
The stock price has gained momentum this year, rising 24%, after a tough 2022. Last year, Intuitive shares slipped 26%. And headwinds like rising inflation and coronavirus disruptions in China weighed on earnings. Today, you might be wondering if this stock moving back up still represents a buying opportunity -- or if gains are limited. Before you make a move, let's consider the bear and bull cases.
The bad news is that the challenges Intuitive faced last year may not yet be over. Higher inflation continues to weigh on companies' costs. And negative currency impact and coronavirus disruptions remain potential problems that could arise at any time. Meanwhile, the stock has climbed quite a bit. And that leaves it trading for 60 times forward earnings estimates -- its highest this year by that measure.
Source Fool.com
Vinci S.A. Aktie
Aktuell gibt es mit 0 Sell-Einschätzungen und 1 Buy-Einschätzungen noch kein wirkliches Sentiment für die Vinci S.A. Aktie.
Das Community-Kursziel von 120 € für Vinci S.A. deutet auf ein leicht positives Wachstumspotenzial gegenüber 111.1 € hin.
